Ann: Human Trial Prelim Results Shows Reduction in Tumour Markers, page-84

Seems like the people who bought in at the start of the week expecting this stock to sky rocket due to the release of the drug trials are dumping due no other news or movement happening. I'm a bit skeptical at this stage myself as what was released at the start of the week is no reason to get excited about and from the companies perspective of not having released anything substantial for quite some time, this weeks announcement was perfect for attracting new share holders.


Time will tell suppose and the only real thing current shareholders, long term and short, can do is just wait and see what results the company publishes within the next few months